Real-world clinical outcomes of pazopanib immediately following immunotherapy discontinuation for the treatment of advanced renal cell carcinoma.-MedSci.cn

Real-world clinical outcomes of pazopanib immediately following immunotherapy discontinuation for the treatment of advanced renal cell carcinoma.

Cao, XT; Tang, D; Ratto, BE; Poole, A; Ravichandran, S; Jin, LX; Gao, W; Swallow, E; Vogelzang, NJ

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (7):

科室
- - 订阅+
  - 更多科室
工具
服务